Escalon Medical Corp (ESMC) stock
ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026Market cap $2.72MP/E 0.7Yield –
Escalon Medical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Escalon Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$407.03K, down 208.0% year over year. For fiscal 2026 it was -$407.03K, down 208.0% from the year before. The highest annual figure on record is $829.32K in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$407.03K | -208.0% |
| FY2025 | Jun 30, 2025 | $376.85K | – |
| FY2024 | Jun 30, 2024 | -$643.06K | -301.9% |
| FY2023 | Jun 30, 2023 | $318.46K | – |
| FY2022 | Jun 30, 2022 | -$1.05M | -226.6% |
| FY2021 | Jun 30, 2021 | $829.32K | – |
| FY2020 | Jun 30, 2020 | -$228.25K | – |
| FY2019 | Jun 30, 2019 | -$494.81K | -739.4% |
| FY2018 | Jun 30, 2018 | $77.38K | – |
| FY2017 | Jun 30, 2017 | -$506.00K | – |
| FY2016 | Jun 30, 2016 | -$1.08M | – |
| FY2015 | Jun 30, 2015 | -$492.79K | – |
| FY2014 | Jun 30, 2014 | -$645.15K | – |
| FY2013 | Jun 30, 2013 | -$1.94M | – |
| FY2012 | Jun 30, 2012 | -$713.70K | – |
| FY2011 | Jun 30, 2011 | -$767.28K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$251.18K | -2214.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $280.98K | +815.4% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$517.42K | -271.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $80.59K | +141.8% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $11.88K | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $30.70K | -83.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $300.94K | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $33.33K | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$349.12K | -198.4% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $184.44K | -21.2% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$344.09K | -964.9% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$134.29K | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $354.93K | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $234.13K | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $39.79K | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$310.38K | -352.1% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$452.80K | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$393.39K | -185.1% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$1.08K | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $123.14K | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$518.63K | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $462.12K | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$169.51K | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$2.22K | -141.8% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$116.94K | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$122.66K | -133.6% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$260.53K | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $5.33K | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$4.34K | -103.4% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $365.14K | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$106.67K | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$176.73K | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $126.18K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$115.34K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$351.25K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$165.58K | – |
See a number that looks wrong?